Searched for
NICHE API
Time to think of the repair cycle? 8 engineering stocks from India’s capital goods ecosystem with upside potential of up to 26%- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%
- Holding stocks is harder than finding them: 10 mid- and small-caps stocks that may be worth holding on to
- ET at Apple’s Bengaluru developer showcase: The apps headed to WWDC 2026Indian developers are showcasing innovative apps for the Apple ecosystem. These apps focus on personal experiences, design, and AI. Develop...11 May, 2026, 02.11 PM IST
- RPG Life Sciences bets big on API business, eyes GLP-1 entry by August-SeptemberRPG Life Sciences is prioritizing its API business for future growth, planning a significant acquisition to scale operations. The company a...30 Apr, 2026, 11.41 PM IST
- From users to builders: How AI and low-code are rewriting who builds softwareCitizen development and AI-driven “vibe coding” are reshaping how software is built inside organisations, shifting creation power from IT t...12 Apr, 2026, 02.03 PM IST
- Narendra Solanki sees limited IT growth, bets on rural and pharma playsInvestors are becoming selective, focusing on earnings visibility and strong balance sheets. Opportunities are emerging in sectors like IT,...09 Apr, 2026, 10.54 AM IST
- Trump tariffs hit patented drugs: Jefferies, Nomura explain impact on pharma stocksThe US has slapped up to 100% tariffs on patented drugs, sparing generics and biosimilars but exposing India’s speciality pharma players. S...06 Apr, 2026, 10.14 AM IST
- Biocon denies plans to sell $1.5 billion generic API businessBiocon API business: Biocon has refuted claims of considering the sale of its generic active pharmaceutical ingredient (API) business, valu...15 Dec, 2023, 01.16 PM IST
- Concord Biotech's niche strengths seen buoying earnings: AnalystsShares of the Ahmedabad-based biopharma company, which listed a few weeks ago at a more than 20% premium, have notched another 9% gain sinc...25 Sep, 2023, 05.45 AM IST
- Concord Biotech's niche API play holds promise for growthET Intelligence Group: Ahmedabad-based Concord Biotech is a global supplier of bio-pharmaceutical APIs and formulations, serving more than ...04 Aug, 2023, 06.02 AM IST
- Ami Lifesciences appoints Amit Kaptain as CEOAs part of the Ami Lifesciences senior management team, Kaptain will be responsible for building business strategy and longstanding global ...15 Sep, 2022, 09.01 PM IST
- Buy, sell or hold: What should you do with Supriya Lifescience after solid debut?“We like Supriya for its niche product portfolio, backward integrated business model and robust financials. It is well placed to tap the op...28 Dec, 2021, 12.23 PM IST
- Supriya Lifescience lists at 55% premium over issue priceThe Rs 700 crore-IPO by the API manufacturer was sold from December 16 to 20 and was subscribed nearly 72 times, with the IPO getting fully...28 Dec, 2021, 10.00 AM IST
- Carlyle, Viyash Life Sciences to launch pharma investment platformCA Hull Investments, an affiliated entity of Carlyle Asia Partners and Viyash, and the platform will primarily focus on investment in Activ...16 Nov, 2021, 05.34 PM IST
- Hikal hits upper circuit after it signs a multi-year dealHikal said it has signed a multi-year contract with a leading global pharma company, which entails development and supply of a portfolio of...05 May, 2021, 12.56 PM IST
- Hikal inks 10-year multi-product deal with global pharma company for APIsThe company has signed a multi-year contract with a leading global pharmaceutical company. This contract entails the development and supply...05 May, 2021, 11.10 AM IST
- Buy Neuland Laboratories, target Rs 920: HDFC SecuritiesNeuland Laboratories is a smallcap company, operating in pharmaceuticals and health care sector.20 May, 2019, 02.54 PM IST
- SeQuent unit gets establishment inspection report from USFDADrug firm SeQuent Scientific today said it has received a report from the US health regulator, indicating closure of inspection of its plan...10 Nov, 2015, 02.06 AM IST
- Positive on API manufacturers, prefer Sequent Scientific: Prakash DiwanThe buying of warrants by the promoter group of Sequent Scientific reflects their confidence in the business, points out Diwan.16 Apr, 2015, 08.13 AM IST
Load More
